Serum biomarkers of VEGF-A and TGF-beta 1 predict pathological response and survival of esophageal cancer patients treated with neoadjuvant chemoradiotherapy and esophagectomy

臺大醫院;臺大醫院-外科部;臺大醫院-腫瘤醫學部;Cheng, Jason Chia-HsienJason Chia-HsienChengChiang, YunYunChiangHsu, Feng-MingFeng-MingHsuTsai, Chiao-LingChiao-LingTsaiHsu, Chih-HungChih-HungHsuLee, Jang-MingJang-MingLee成佳憲2017-12-212018-07-092017-12-212018-07-092016http://ntur.lib.ntu.edu.tw//handle/246246/284139[SDGs]SDG3Serum biomarkers of VEGF-A and TGF-beta 1 predict pathological response and survival of esophageal cancer patients treated with neoadjuvant chemoradiotherapy and esophagectomy10.1158/2326-6074.CRICIMTEATIAACR15-A002